These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18250342)

  • 1. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
    Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
    Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk colorectal adenomas and serum insulin-like growth factors.
    Renehan AG; Painter JE; Atkin WS; Potten CS; Shalet SM; O'Dwyer ST
    Br J Surg; 2001 Jan; 88(1):107-13. PubMed ID: 11136321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
    Ahmed RL; Thomas W; Schmitz KH
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men.
    Giovannucci E; Pollak M; Liu Y; Platz EA; Majeed N; Rimm EB; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):84-9. PubMed ID: 12582016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.
    Holmes MD; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):862-7. PubMed ID: 12223430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
    Flood A; Mai V; Pfeiffer R; Kahle L; Remaley AT; Rosen CJ; Lanza E; Schatzkin A
    Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
    Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
    Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY; Choi BG; Choi JY; Lee SY; Ju SY
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium and colorectal adenoma: results of a pooled analysis.
    Jacobs ET; Jiang R; Alberts DS; Greenberg ER; Gunter EW; Karagas MR; Lanza E; Ratnasinghe L; Reid ME; Schatzkin A; Smith-Warner SA; Wallace K; Martínez ME
    J Natl Cancer Inst; 2004 Nov; 96(22):1669-75. PubMed ID: 15547179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
    Vrieling A; Rookus MA; Kampman E; Bonfrer JM; Bosma A; Cats A; van Doorn J; Korse CM; Witteman BJ; van Leeuwen FE; van't Veer LJ; Voskuil DW
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2585-93. PubMed ID: 18842999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.